In terms of clinical trials, 60 cases of R/R T-ALL/LBL were treated with anti-CD7 CAR (NS7CAR) T cells, with 94.4% of the patients achieving bone marrow CR after 28 days. The gene discussed is CD7; the disease is acute lymphoblastic leukemia.